Search Results For ''

  • Atlanta Falcons turn to Australians to solve lead-blowing woes

    While Australian influence on the field of America’s National Football League (NFL) is growing, the bigger influence is coming off the field with sports tech and data analytics company Catapult (ASX: CAT) contracted by all 32 teams in the league now that the Atlanta Falcons are sick of losing, and have signed up.  The Falcons,

    Read More
    Public
  • Millenials get happy! Alterra is making your smashed avo dreams come true

    Progressing their next-gen 300-hectare avocado project in Western Australia, sustainable agriculture specialist Alterra (ASX:1AG) could soon be extending the live-at-home lives of millenials that continue to prioritise smashed avo cafe breakfasts ahead of financial independence. The Company has released an update today on the progress of their flagship 300-hectare avocado project. The Carpenters Project, located

    Read More
    Public
  • Qantas boss pumped for NZ bubble despite $11 billion loss of revenue

    News of the international travel bubble between Australia and New Zealand is music to the ears of Qantas (ASX: QAN) CEO Alan Joyce, who has probably endured the toughest gig amongst top executives having had to navigate $11 billion in lost revenue through no fault of their own. While the airfares will be one way

    Read More
    Public
  • Meghan Markle blames bad Zoom connection for not attending Prince Phillip’s funeral

    Despite the supposed influence Meghan Markle possesses, shares in tech company Zoom (NASDAQ: ZM) remained unfazed after she blamed the video meeting tech as a reason for not attending Prince Phillip’s funeral. Markle’s initial reason for not accompanying her husband to the funeral was the fact she is 6-months pregnant and a flight to London

    Read More
    Public
  • Pharmaxis streamlines operations with $2m sale of Russian distribution rights

    Streamlining operations to focus on the most profitable side of their pharmaceuticals manufacturing business, Pharmaxis (ASX: PXS) has shored up its cash position via the sale of distribution rights in Russia for their cystic fibrosis treatment which is gathering international momentum. The deal will send exclusive distribution rights in Russia to specialty company GEN İlaç

    Read More
    Public
  • Who’s top of the class post pandemic in the listed education sector?

    With our international borders still resolutely padlocked, the absence of foreign students poses an ongoing existential threat to our universities and other parties feeding off the education ecosystem (such as student accommodation providers). The listed education providers have not been immune, although arguably those exposed to the foreign student trade have not fared as badly

    Read More
    Public